Prenatal diagnosis of non‐immune hydrops fetalis: what do we tell the parents?
Prenatal Diagnosis2011Vol. 31(2), pp. 186–195
Citations Over TimeTop 10% of 2011 papers
Susana Santo, Sahar Mansour, B. Thilaganathan, Tessa Homfray, Aris T. Papageorghiou, Sandra Calvert, Amar Bhidé
Abstract
The survival rate of NIH is at least 48% in this study. Prenatal identification of the cause is possible in 56% of cases. The risk of neurodevelopmental delay in those that survive is 3 of 28 (11%).
Related Papers
- → Nonimmune hydrops fetalis: identifying the underlying genetic etiology(2018)72 cited
- → Characterization of Hb Bart’s Hydrops Fetalis Caused by – –SEAand a Large Novel α0-Thalassemia Deletion(2018)9 cited
- → Invasive prenatal diagnosis of α-thalassemia to control Hb Bart’s hydrops fetalis syndrome: 15 years of experience(2018)14 cited
- A Case of Nonimmune Hydrops Fetalis Caused by Homozygous α-Thalassemia Homozigot α-Talasemiye Bağli Gelişen Bir Nonimmün Hidrops Fetalis Olgusu(2012)
- → Progress in etiological analysis, diagnosis and treatment of hydrops fetails(2018)